Meningitis outbreak toll: 404 cases, 29 deaths

November 2, 2012 by The Associated Press

An outbreak of fungal meningitis has been linked to steroid shots for back pain. The medication, made by a specialty pharmacy in Massachusetts, has been recalled.

Latest numbers from the :

Illnesses: 404, including nine joint infections.

Deaths: 29.

States: 19; Florida, Georgia, Idaho, Illinois, Indiana, Maryland, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas and Virginia.

Explore further: Meningitis outbreak toll: 386 cases

More information: CDC: www.cdc.gov/HAI/outbreaks/meningitis.html

shares

Related Stories

Meningitis outbreak toll: 386 cases

November 1, 2012
An outbreak of fungal meningitis has been linked to steroid shots for back pain. The medication, made by a specialty pharmacy in Massachusetts, has been recalled.

Meningitis outbreak toll: 119 cases, 11 deaths

October 9, 2012
(AP)—The number of people sickened by a deadly meningitis outbreak has now reached 119 cases, including 11 deaths.

Steroid-related meningitis cases rise to 105

October 8, 2012
(AP)—Health officials say the number of people sickened by a deadly meningitis outbreak has now reached 105 cases.

CDC: More than 90 people ill with meningitis

October 7, 2012
(AP)—Health officials say they have now confirmed more than 90 cases of a rare fungal meningitis that has been linked to a steroid commonly used to ease back pain.

Meningitis outbreak deaths rise to 19

October 17, 2012
(AP)—Health officials say four more people have died in the national meningitis outbreak, bringing the number of deaths to 19.

US : Fungus in tainted steroids and patients match (Update 2)

October 18, 2012
(AP)—The fungus found in tainted steroid shots matches the one blamed in the national meningitis outbreak that has killed 20 people, federal health officials said Thursday.

Recommended for you

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.